Quantcast

Latest Antibiotic-resistant bacteria Stories

MRSA out of africa
2014-08-28 03:00:56

Jim Sliwa, American Society for Microbiology The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio®, the online open-access journal of the American Society for Microbiology. CA-MRSA refers to MRSA infections occurring in healthy people with no recent hospitalizations. The...

2014-08-27 23:02:28

A Black Book survey of nearly 1,000 hospital executives and clinical leaders probed emergency preparedness and infectious disaster resource capabilities including technology and services. The resulting responses uncovered ten common yet precarious situations that collectively restrict nearly all U.S. hospitals regardless of size or location to efficaciously diagnose, isolate and treat even a single Ebola patient while protecting its workforce and other patients. New York, NY (PRWEB) August...

2014-08-26 08:30:26

SANTA ROSA, Calif., Aug. 26, 2014 /PRNewswire/ -- Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee (DMC) to begin enrolling patients in the Company's planned Phase 1/2 clinical trial. RUT58-60 is intended for use as an adjunct therapy in combination with prophylactic...

2014-08-26 08:30:16

ROCKVILLE, Md., Aug. 26, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile), will be presented at the Infectious Disease Week (IDWeek 2014(TM)) held by...

2014-08-22 12:25:38

Control allows users to monitor assay performance with confidence MILFORD, Mass., Aug. 22, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN(®) 501 C. difficile Control - the company's first molecular control product targeting hospital acquired infections....

2014-08-19 08:29:22

-- Two of Company's Anti-Infective Programs to be Presented at Highly Regarded Scientific Conference: Pertussis and C. difficile -- ROCKVILLE, Md., Aug. 19, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that its novel C. difficile development program will be highlighted at the 54(th) Interscience...

2014-08-13 08:29:35

CHICAGO, Aug. 13, 2014 /PRNewswire-USNewswire/ -- Antibiotic resistance continues at an alarming rate with the indiscriminate overuse of antibiotics given to humans and animals. The number one pathogen is MRSA - methicillin-resistant Staphylococcus aureus, an antibiotic resistant form of Staphylococcus and at epidemic levels in the United States and worldwide. MRSA and antibiotic resistance (AR) must to be a top political priority. "How can we ever hope to control an Ebola or SARS...

Pseudomonas aeruginosa bacteria
2014-08-07 02:00:05

The University of Edinburgh Findings about how bacteria cooperate to cause infection may help spot diseases that might jump from animals to people. Bugs that can cooperate best with each other are most likely to be able to jump to new species, including humans, a new study shows. Bacteria interact by releasing molecules to help them adapt to their environment - for example, when killing competing infections in their victim. They coordinate these actions by releasing tiny amounts...

2014-08-05 23:01:34

The new products are designed to offer the latest technology at the best prices. Sylmar, CA (PRWEB) August 05, 2014 Kleritec announced today the expansion of their disinfectant and cleaning offerings, in light of recent news from both the FDA and the CDC about antibiotic-resistant bacteria. Among the new products from Kleritec is Medistaph Hand Wipes, Formula 10, and Disinfectant Spray. The Medistaph Wipes protect against MRSA and other antibiotic-resistant bacteria, and can be used for...

2014-08-05 08:32:23

-- Executed Agreement with Evonik for Formulation Development, Analytical Services andClinical Drug Manufacturing -- ROCKVILLE, Md., Aug. 5, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today announced that, with a new multi-service agreement in place, the Company is on track to initiate Phase Ia and Ib clinical trials of...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related